• US company developing a modified release formulation for an existing active ingredient needed full support with all routine PV activities, as well as migration of the global safety database
  • Expanding to new markets and awaiting approval in EU and Canada
  • Needed support for introduction of new products into the EU as well as further expansion in the US
  • Needed local presence in the EU to liaise with their marketing partners without the need to set up their own infrastructure
  • Dynamic growth of company required flexible up- and down-scaling of resources